Delivery Order SPE2DB20D3101-SPE2DB23FRUP3

Award Date 8/10/23
Potential Completion Date 8/11/23
Potential Value $5.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $18,281 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg Emverm tablets. As the prime contractor, Amerisourcebergen will provide approximately 18,000 tablets to support the Defense Logistics Agency's medical supply needs. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania distribution facility. The single day order period, July 17-18, 2023, aligns with the Defense Logistics Agency's mission to maintain...
The Defense Logistics Agency awarded a $1,235.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg EMVERM chewable tablets. As the prime contractor, Amerisourcebergen will deliver the prescription medication to an address in Conshohocken, Pennsylvania under a one-day period of performance between August 10-11, 2023. No subcontractors or set aside designations were indicated. The delivery order was issued against an existing DLA contract vehicle to support the...
The Defense Logistics Agency awarded a $3,943.53 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg chewable Emverm tablets. As the prime contractor, Amerisourcebergen will supply the anti-parasitic medication to support DLA's medical countermeasures programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late August 2023. No subcontractors or set aside designations were identified. DLA routinely issues...
The Defense Logistics Agency Troop Support Medical awarded a $55,835.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg EMVERM chewable tablets. The contract has a period of performance from July 3, 2023 through July 5, 2023, with performance taking place in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity...
The Defense Logistics Agency awarded a $29,436.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562179691 EMVERM 100 MG TABLET CHEW UDS. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the specified medication to a facility located in Conshohocken, Pennsylvania, with performance required between September 14-15, 2023. As a...
The Defense Logistics Agency awarded a $4,262.15 delivery order to Amerisourcebergen Drug Corporation for 4561664086 EMVERM 100 MG TABLET CHEW UDS. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the specified pharmaceutical products from its facility in Conshohocken, Pennsylvania to an unknown customer of the Defense Logistics Agency. Performance is required from August 1-2, 2023 under a firm fixed price contract. No set aside designation or...
This is a $28,668.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of EMVERM 100 mg chewable tablets. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999, which enables DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support...
The Defense Logistics Agency awarded a $617 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg EMVERM tablets to be delivered by October 19, 2023. The place of performance is Conshohocken, Pennsylvania. No set-aside provisions were specified in the award. As a major pharmaceutical supplier, Amerisourcebergen will fulfill this order from its corporate headquarters to provide the Defense Logistics Agency with the requested generic medication in support of its...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at approximately $1,852 under contract number 4561890407 by the Defense Logistics Agency Troop Support Medical (DLA). The delivery order is to provide 100mg Emverm tablets for use by DOD personnel. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from August 21 to August 22, 2023. No subcontractors...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,278.76 Firm Fixed Price Delivery Order contract is for the supply of the medication EMVERM 100 MG TABLET CHEW UDS. The award has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRUP3
    Delivery Order

The Defense Logistics Agency awarded a $5,297.51 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg Emverm tablets to be delivered to a location in Conshohocken, Pennsylvania between August 10-11, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will fulfill the order for the chewable anti-parasitic drug tablets on behalf of the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense, to likely support the medical readiness of military personnel. No set aside designation or subcontractors were indicated in the award information.

Generated 12/23/23, 11:28 AM